Public releases
2015

2015 annual results

2016/03/14 - Financial public releases

2015 annual results heavily impacted by the United States

Read more

2015 Annual consolidated sales

2016/01/14 - Financial public releases

Annual sales growth of 10.2%, driven by exchange rates and acquisitions

Read more

2015 third quarter consolidated sales

2015/10/15 - Financial public releases

Virbac : sales grow by 5.5% in the third quarter

Read more

2015 half year results

2015/09/15 - Financial public releases

Half-year results  heavily impacted by the United States

Read more

2015 second quarter consolidated sales

2015/07/16 - Financial public releases

Virbac : sales grow by 18.1% in the first half

Read more

Group's perspectives for 2015 impacted by the industrial situation in the United-States

2015/06/23 - Financial public releases

Group’s perspectives for 2015 impacted by the industrial situation in the United-States

Read more

2015 first quarter consolidated sales

2015/06/15 - Financial public releases

Sales growth of 17.1% in the first quarter

Read more

PEA-PME eligibility of Virbac

2015/03/24 - Financial public releases

Virbac, listed on Euronext Paris

Read more

Virbac announces the closing of the SENTINEL® brands family acquisition in the United States

2015/01/05 - Financial public releases

Virbac announces the successful closing on January 2nd of its agreement with Eli Lilly and Company to acquire two major parasiticides for dogs in the United States: SENTINEL® Flavor Tabs® and SENTINEL® SPECTRUM®, marketed up to now by Novartis Animal Health.

Read more